Dileucine is a molecule composed of two amino acid residues of leucine linked by peptide bonds. In studies concerning muscle nutrition and metabolism, this name most often refers to the linear dipeptide L-leucyl-L-leucine, written as Leu–Leu or DILEU [1].
Although Duleucin consists of a well-known amino acid, it is not chemically identical to the mixture of two free molecules of leucine.
This difference has become the subject of research into amino acid metabolism, short-term protein synthesis in muscle, and adaptations to resistance training.
In some of the experiments, interesting physiological changes were observed, including an increased short-term rate of muscle protein synthesis and differences in selected results of strength training.
However, this does not mean that dileucine provides greater and more lasting muscle mass growth.
Available human studies involve relatively small groups, differ in the composition of the comparator preparations, and analyze different endpoints.
Some measure protein synthesis within a few hours, others measure exercise results, and still others measure changes in amino acid concentrations in the blood.
The article explains what dileucine is, how it differs from leucine, what results have been obtained in studies in humans and in the laboratory, and why short-term observations do not yet constitute evidence of long-term muscle growth.
What is dileucine? Name and chemical identity
Dileucine is a dipeptide formed by the combination of two leucine residues through a peptide bond.
In the scientific literature, several names for this substance can be found:
- dileucine;
- L-leucyl-L-leucine;
- L-leucine;
- Leu–Leu;
- DILEU.
These names may refer to the same linear dipeptide, provided that both of the remaining amino acids have the L configuration [1].
Two free amino acids leucine found in one solution are not the same chemical compound.
In the disucylation process, the remaining amino acids form a single molecule linked by covalent peptide bonds.
This structural difference forms the basis for research into possible differences in transport, metabolism, and biological responses.
Do dileucine and the dileucine motif mean the same thing?
No.
In molecular biology, the term „dileucine motif” can refer to two adjacent leucine residues occurring within a much larger protein.
Such motifs are sometimes analyzed in the context of protein sorting, intracellular transport, and the movement of molecules between cell compartments.
These are not automatically studies concerning the consumption of free dipeptide L-leucyl-L-leucine.
Including such publications in the analysis of the effectiveness of diethylene glycol as a dietary ingredient would lead to mixing two different issues.
Does every substance described as dileucine have the same structure?
This cannot be assumed without an appropriate specification.
Among others, they have the following meanings:
- linear or cyclic peptide structure;
- stereochemical configuration of the amino acid residues;
- the presence of additional amino acid residues;
- a form of water-filled or waterless;
- the composition of the entire preparation.
The result obtained for a particular form of dileucine does not necessarily apply to every other form.
This also applies to products containing additional amino acids or other nutrients.
Is dileucine a peptide, a protein or a component of a supplement?
Dileucine is a dipeptide, which is a compound containing two amino acid residues linked by a peptide bond.
Peptides are among the simplest peptide structures.
Dileucine is not a complete protein, an anabolic steroid, or a class of pharmacological receptors.
Its classification describes the chemical structure, but in itself it does not confirm any specific effect on strength, muscle mass, or athletic performance.
Why does dileucine not replace a complete protein?
Dileucine contains only the residues of leucine.
It does not provide the remaining exogenous amino acids needed for the synthesis of new structural proteins.
Leucine participates in the regulation of processes related to the metabolism of muscle proteins, but the mere supply of leucine does not provide all the substrates needed to form complete protein chains.
A mechanistic study from 2026 specifically analyzed the importance of the environment of the remaining exogenous amino acids for the cells' response to dileucine [2].
The results indicate that the interpretation of the action of dileucine requires taking into account the entire nutritional context.
How is dileucine different from its related substances?
| Substance or term | What does that mean? | The most important distinction |
|---|---|---|
| Leucine | Single free amino acid | A chemical form other than a dipeptide |
| L-Dileucine | Two remaining L-leucine residues combined by peptide binding | Defined molecule analyzed in nutritional studies |
| Dileucine monohydrate | A dipeptide in the form of water-containing crystallites | The mass of the component also includes bound water |
| Formula EAA with dileucine | A mixture of dipeptide and other exogenous amino acids | The result may depend on many factors |
| Dileucine motif | Two residues of leucine within the larger protein | It usually does not apply to the consumption of isolated dileucine. |
Distinguishing these concepts is particularly important when reviewing scientific studies.
Publications on cell biology, food analysis, and nutritional interventions may use similar names, even though they examine different molecules or phenomena.
Molecular structure of dileucine, hydration and composition of preparations
The basic structural feature of dileucine is the peptide bond that links the two leucine residues.
However, the full characteristics of the research material require additional information.
The stereochemistry, chemical form, water content, and the actual amount of dipeptide in the sample must be taken into account.
The mass of the bold powder does not always correspond to the mass of anhydrous L-leucyl-L-leucine.
Why is dihydrat dileucine important?
In a training study published in 2024, a preparation known as dileucine monohydrate was used [3].
Monohydrate contains water associated with the crystalline form of the substance.
This means that the total mass of the component includes both the dipeptide and the water.
This information is important when comparing different preparations.
However, this does not mean that all products labeled with the name diethylene glycol have the same composition or the same content of the active dipeptide.
Does high chromatographic purity confirm the exact content of dileucine?
No.
Chromatographic purity, quantitative determination of the component and measurement of moisture correspond to various analytical questions.
The chromatographic purity result describes the proportion of the detected components under the conditions of the applied method.
It does not allow the user to independently determine how many milligrams of the target dipeptide are present in the prepared portion of the product.
Similarly, information about the mass of a component does not replace the actual content of its composition.
Why does the study of amino acid mixtures require careful interpretation?
A 2025 study analyzed a preparation of exogenous amino acids containing dileucine [4].
It was compared with other nutritional blends.
Because the preparations differed more than just the presence of dileucine, the results did not constitute a direct test of adding only this dipeptide to an identical formulation.
Therefore, it is not possible to automatically attribute all observed differences to a single component.
Scientific studies on dileucine in humans and in the laboratory
Research on dileucine focuses on amino acid metabolism, muscle protein synthesis, training adaptations, and cellular responses.
The available publications differ in terms of the project, the number of participants, and the parameters evaluated.
Therefore, their results should be analyzed separately.
2021 study – short-term synthesis of muscle proteins
Ten healthy young men participated in a randomized, double-blind, cross-over study [1].
The researchers compared dileucine with equal mass of free leucine.
During the three-hour measurement period, the rate of synthesis of myofibroblast proteins was evaluated, among other things.
The following values were obtained:
- after dilucination: about 0.075% per hour;
- after free leucine: about 0.047% per hour.
The result indicated a higher short-term rate of myofibrillary protein synthesis under the study conditions after dileucine.
However, a statistically significant difference was not found in the breakdown of muscle proteins.
No significant difference in serum exposure to leucine was also shown between the compared conditions.
What does this result mean?
The study provided information about the short-term physiological response.
It was not limited to measuring the individual marker of the signaling path.
However, this does not mean that a three-hour increase in protein synthesis allows muscle growth to be predicted after several months of training.
It was also not confirmed that dileucine causes greater total absorption of leucine.
The study did not find a significant difference in her serum exposure.
The cross-over design allowed the comparison of the responses of the same participants under different conditions.
This was beneficial in limiting the portion of individual differences.
However, a group of ten young men does not allow to determine whether similar effects occur in women, older people, patients with chronic diseases, or people who follow other nutrition models.
Dileucine and resistance training – a 2024 study
In a ten-week study, groups receiving dileucine, free leucine, and placebo were compared [3].
The study included 34 participants.
The resistance training results were evaluated, including selected parameters of the leg press exercise, i.e., pressing the weight with the legs.
What differences were observed?
In the dileucine group, there was a greater improvement in maximum weight in one leg press repetition compared to placebo.
A greater improvement in the number of repetitions performed to fatigue was also observed compared to the leucine group.
These are two different endpoints and two different comparisons.
This does not mean that dileucine was better than all the other conditions in all measurements.
Did the study confirm greater muscle mass gain?
No.
Comparisons of body composition did not show statistically significant differences between the groups.
The improvement in the resistance exercise result may result from various adaptations.
These include, among other things, improved movement control, neuromuscular coordination, and changes related to training.
Therefore, a favorable result in the leg press should not be automatically presented as evidence of greater muscle hypertrophy.
What were the limitations of this study?
The publication described the loss of some participants during the study, retrospective registration, and commercial funding or conflicts of interest of the authors.
These elements require a clear presentation.
They do not automatically mean that the results obtained are incorrect.
However, the importance of an independent repeat study, the earlier determination of endpoints, and the complete reporting of all results increases.
2025 study – dileucine in a mixture of exogenous amino acids
12 healthy adults participated in a randomized cross-over study, including eight men and four women [4].
The preparation of exogenous amino acids containing D-leucine was compared with the BCAA branched-chain amino acid formulation and collagen hydrolysate.
What was shown in the study?
The preparation containing dileucine and the BCAA formulation compared showed similar retention of leucine derived from the indicated preparation.
In both cases, the result was higher than after collagen hydrolysis.
No significant difference was found in the protein degradation index used based on urine measurements.
Additional exploratory experiments using participants' fibroblasts and muscle cells did not show a consistent advantage in all analyzed cellular parameters.
Can the result be attributed solely to dileucine?
No.
The formulations compared differed in the composition of more than one component.
Therefore, it cannot be established that every observed response was caused by dileucyn.
The results refer to complete preparations evaluated in the study.
This is an important principle of nutritional research: a favorable comparison of two mixtures does not automatically prove the superiority of a single component of one of them.
Dileucine in food studies and mechanistic experiments from 2026
Two publications from 2026 provided additional information regarding dileucine.
The first analyzed the relationships between food consumption and the concentration of dileucine in the blood.
The second concerned cellular responses in a specific amino acid environment.
Analysis of post-dose changes in dileucine concentration
In a secondary analysis of two studies involving a total of 26 adults, the concentration of delucine in the blood was evaluated after the consumption of various food products and beverages [5].
A significant increase in the serum concentration of dileucine was observed in a condition involving lean pork.
The maximum concentration of dileucine showed a moderate relationship with the change in the indicator of muscle protein synthesis.
However, this was an analysis of pop-culture dependencies.
It did not constitute an intervention allowing the isolation of the effect of the supplemented dileucine.
Food provides many nutrients that can influence the metabolic response.
The correlation itself does not confirm a causal relationship.
Mechanistic study from 2026
A separate publication analyzed C2C12 myocytes, a laboratory model of muscle cells, and observations regarding signaling in humans [2].
In cell experiments, dileucine alone did not elicit the response observed after leucine alone.
In the presence of the remaining exogenous amino acids, both D-leucine and L-leucine supported protein synthesis-related responses.
However, dileucine did not show any advantage in this comparison.
These results emphasize the importance of the amino acid environment.
They also help to understand why the results regarding a single molecule should not be interpreted in isolation from the other nutritional components.
Cellular experiments can explain mechanisms, but they do not replace direct measurements of force, muscle size, or the functions of the human body.
How can dileucine affect the metabolism of muscle proteins?
The main research question concerns whether the provision of two residues of leucine in the form of a combined dipeptide alters transport, metabolism, or signaling in a way that affects the metabolism of muscle proteins.
This hypothesis is a valid subject of research.
However, this does not mean that every proposed mechanism has already been confirmed.
Does dileucine improve the absorption of leucine?
A 2021 study did not confirm a significant difference in plasma exposure to leucine between dileucine and free leucine [1].
The higher short-term rate of protein synthesis does not unequivocally indicate which transport mechanism was responsible for the observed difference.
Therefore, this experience should not be described as evidence of a much better absorption of leucine.
Appropriately designed measurements of transport and metabolism would be needed to confirm such a mechanism.
What role do the other exogenous amino acids play?
The process of protein synthesis requires access to all the appropriate amino acid substrates.
Cellular signals can initiate or regulate synthesis, but they do not replace the amino acids necessary for the construction of protein chains.
Results from 2026 indicate that the response to dileucine depends on the availability of the remaining exogenous amino acids [2].
Dileucine therefore does not replace the complete set of amino acids needed by the body.
Why are different protein metabolism indicators not equivalent?
The studies can measure:
- dileucine concentration in the blood;
- free leucine concentration;
- leucine retention;
- activity of signaling proteins;
- the speed of muscle protein synthesis;
- the rate of protein breakdown;
- changes in strength;
- long-term muscle hypertrophy.
Each of these parameters describes a different aspect of biology.
The consistency of several results can strengthen a particular interpretation.
However, a favorable result in one measurement does not replace the missing data regarding the others.
The most important limitations of studies on dileucine
Small groups of participants and short observation time
The cited studies involve relatively small groups of people.
Some only evaluate metabolism for a few hours.
Such projects allow the study of specific physiological responses, but do not establish long-term safety or lasting changes in muscle mass in different populations.
The ten-week training study provides functional information, but its size and duration still limit the possibility of generalizing the results.
Different comparison groups answer different questions
The comparison of the equal mass of diethylene glycol and leucine is not identical to the comparison of the equivalent amount of residual leucine, nitrogen, or two EAA mixtures with the same composition outside the component under study.
Each project allows for answering a slightly different question.
Therefore, claims about the superiority of dileucine should always indicate a specific comparator group and the measured parameter.
Improvement in strength does not automatically confirm hypertrophy
The outcome of resistance training can improve without a detectable increase in muscle size.
Since the training study did not show a significant advantage in body composition, the selected leg press results should not be presented as a general guarantee of muscle mass development [3].
Safety data are incomplete
Small nutritional studies do not allow the exclusion of rare or delayed adverse reactions.
They also do not establish safety for all populations, including children, pregnant women, and people with chronic diseases.
The absence of a reported problem is not equivalent to confirmation of universal safety.
Independent research and transparent reporting are needed
Commercial funding should be disclosed and evaluated in the context of the research methodology.
It does not in itself constitute evidence of irregularities.
Stronger evidence would require repeated studies, prior registration of endpoints, appropriate nutritional comparisons, and reliable measurements of muscle mass, fitness, and safety.
Frequently asked questions about dileucine
1. Does dileucine mean a specific substance?
In this article, dileucine means the linear dipeptide L-leucyl-L-leucine. However, the context is important because the monohydrate of dileucine, a multi-constituent preparation and the dileucine motif within the larger protein are not identical materials. Before comparing the results, it is necessary to determine the stereochemistry, chemical form, and formulation composition. The mere name agreement does not guarantee that the same intervention was used in the two studies.
2. What do the available studies on dileucine confirm?
The studies confirm selected short-term metabolic responses and differences in some training parameters. However, they do not confirm a consistent increase in muscle mass or a general advantage of D-leucine over other nutritional strategies [1,3]. Conclusions should take into account the studied population, the comparison group, and the specific endpoint. Protein synthesis over several hours, training results, and body composition are separate issues.
3. Is Dileucine the same as Leucine?
No. Dicalcium phosphate contains two residues of leucine linked by a peptide bond, whereas leucine is a single free amino acid. Their chemical similarity justifies conducting comparative studies, but it does not mean identical metabolism. The presence of a peptide bond changes the molecule’s identity, although this difference alone does not dictate absorption or physiological effects.
4. Is Dicalcium Phosphate a complete protein?
No. Dicalcium phosphate contains only the residues of leucine and does not provide the full set of exogenous amino acids. Mechanistic studies also indicate that the response to dicalcium phosphate depends on the surrounding amino acid environment [2]. Therefore, classifying it as a peptide does not mean nutritional equivalence with complete protein. The synthesis of new proteins also requires other amino acids.
5. Does higher short-term protein synthesis evidence muscle growth?
No. Measuring protein synthesis over a few hours does not confirm sustained hypertrophy. Long-term muscle changes depend on many processes, including training, nutrition, protein breakdown, and regeneration. The short-term response may support the hypothesis, but confirmation of muscle growth requires repeated measurements of their size or body composition over a sufficiently long period.
6. Did the training study show a greater increase in muscle mass?
No statistically significant advantage was shown between groups in body composition measurements. Differences were noted in selected leg press exercise results, but they should not be equated with confirmed hypertrophy [3]. Improvement in strength may also result from better control of the exercise and neuromuscular adaptations. Body composition results should be analyzed with the same caution as the results of strength tests.
7. Is D-leucine better than leucine in every way?
No. The results depend on the type of test and the parameter being analyzed. A favorable difference in one measurement does not automatically confirm superiority in strength, endurance, recovery, body composition, or safety. Such broad claims would require consistent evidence from multiple studies involving appropriate comparison groups and different populations.
8. Does a higher concentration of D-leucine in the blood mean better leucine absorption?
No. The concentration of intact dipeptide and the concentration of free leucine are separate measurements. In a short-term study, no significant difference in serum exposure to leucine was found between the compared conditions [1]. Therefore, conclusions about better overall leucine absorption can not be drawn solely based on the concentration of another molecule. Confirmation of the transport mechanism requires direct studies.
9. Do food studies confirm the effectiveness of dilucyn supplements?
No. Food provides many nutrients that collectively influence metabolic response. A 2026 analysis showed a link between plasma dileucine concentration and a specific protein synthesis indicator, but did not isolate the supplemented dileucine as the cause [5]. Observational studies provide scientific context, but are not direct evidence of the efficacy of a single supplement ingredient.
10. Does the study of the amino acid mixture allow determining the effect of dileucine itself?
Only when the research project properly isolates the effect of this component can the results be compared. In the 2025 study, preparations differing in more than one component were compared [4]. The results therefore concern entire formulations. To determine the contribution of dileucine itself, it would be necessary to compare appropriately matched mixtures that differ only in its presence. Without such a comparison, it is not possible to unequivocally attribute all effects to a single component.
11. Does Dicalcium reduce the breakdown of muscle proteins?
In the studies discussed, a consistent reduction in the breakdown of muscle proteins was not confirmed. Neither in the short-term comparison with leucine nor in the later study of the formulation did a significant difference in the corresponding measurements be observed [1,4]. Increased protein synthesis does not automatically mean a reduction in their breakdown. These are two separate metabolic processes that require separate evaluation.
12. Does the dileucine motif matter for supplementation?
Not always. The dileucine motif can mean two adjacent residues of leucine in a larger protein, rather than a free dipeptide used as a nutritional component. Studies of such motifs may concern intracellular transport and other processes unrelated to the consumption of dileucine. Therefore, before including the publication in the evidence for supplementation, it is necessary to determine what substance or structure was actually studied.
13. Does cellular testing confirm the improvement of sports performance in humans?
No. Cell cultures do not reproduce the full physiology of humans or the training process. They can help analyze molecular mechanisms, but they do not encompass all the factors related to nutrition, physical activity, and the body's adaptation. Claims of improved athletic performance require direct measurements in humans, not just results from cellular signaling tests.
14. Why is the form of dileucine monohydrate important?
Monohydrate contains water, which constitutes part of the total mass of the component. In a 2024 training study, exactly this form of diethylene was used [3]. When comparing the preparations, it is therefore necessary to distinguish the mass of the entire component from the actual content of dipeptide. This is an analytical issue that in itself does not dictate biological effectiveness.
15. Can the results of research on young adults be applied to older people?
This cannot be assumed. Age, health status, physical activity, and diet can all influence metabolic response. The small studies described in the article do not confirm the efficacy of dileucine in the treatment of sarcopenia or other clinical conditions. Such applications would require studies involving an appropriate population, functional endpoints, and systematic safety assessment.
16. Does commercial funding invalidate the results of the study?
No. The funding source alone does not dictate whether the result is correct. However, it does increase the importance of transparent description of methods, disclosure of conflicts of interest, complete reporting of results, and independent replication of the experiment. The evaluation should be based on the quality of the project and the data, rather than on automatic rejection or uncritical acceptance of a study due to sponsorship.
17. What evidence would be needed to confirm the effect of dileucine on muscle growth?
Larger, independently replicated training studies involving objective measurements of muscle size, strength, diet compliance, protocol adherence, and adverse events would be most valuable. Appropriate comparison groups and prior determination of the analyzed results would be important. Only consistent results from such studies would allow assessing whether short-term metabolic responses translate into lasting and significant functional changes.
Applications
Dileucine is a chemically defined dipeptide composed of two leucine residues linked by a peptide bond.
The available literature includes a small but growing group of nutritional studies involving humans.
In part of the experiments, differences in the short-term synthesis of muscle proteins and selected parameters of resistance training were demonstrated.
However, the consistent, long-term increase in muscle mass nor the overall advantage of D-leucine over other nutritional approaches have not been confirmed.
The interpretation of the results requires taking into account the exact form of the component, the type of the comparison group, the characteristics of the participants, and the actually measured parameter.
Available observations should not be either ignored or presented as stronger evidence than they actually are.
Larger, independent and properly controlled studies would be needed to determine whether short-term metabolic differences translate into repeated, long-lasting benefits.
Educational, medical and nutritional reservations
This article is for educational purposes only and serves as a critical interpretation of scientific research. It does not constitute medical advice, diagnosis, an individual nutrition plan, or a recommendation to purchase, administer, combine, or use dileucine or other supplements.
The studies discussed include small human trials and laboratory experiments. Results regarding short-term protein synthesis, selected training parameters, or cellular signaling do not guarantee increased muscle mass, improved health, or safety for an individual.
The composition and quality of the products may differ from the materials used in the studies. Results regarding multi-component preparations should not be automatically attributed to dileucine itself.
Individuals considering changes in diet or supplementation, especially pregnant women, breastfeeding women, minors, and those taking medication or suffering from chronic illnesses, should seek individual advice from a suitably qualified specialist.
References
- Paulussen, K. J. M., Alamilla, R. A., Salvador, A. F., McKenna, C. F., Askow, A. T., Fang, H. Y., Li, Z., Ulanov, A. V., Paluska, S. A., Rathmacher, J. A., Jäger, R., Purpura, M., & Burd, N. A. (2021). The ingestion of dileucine is more effective than leucine in stimulating muscle protein turnover in young males: A double blind randomized controlled trial. Journal of Applied Physiology, 131(3), 1111–1122. https://doi.org/10.1152/japplphysiol.00295.2021
- Tinline-Goodfellow, C. T., Babits, P., Fung, H. J. W., Holowaty, M. N. H., Hodson, N., Abou Sawan, S., Paulussen, K. J. M., Jäger, R., Purpura, M., Burd, N. A., & Moore, D. R. (2026). Dileucine requires essential amino acids to stimulate mTORC1 signaling and muscle protein synthesis in C2C12 myotubes. The Journal of Nutritional Physiology, 7, Article 100041. https://doi.org/10.1016/j.jnphys.2026.100041
- Hagele, A. M., Krieger, J. M., Gaige, C. J., Holley, K. F., Gross, K. N., Iannotti, J. M., Allen, L. E., Sutton, P. J., Orr, L. S., Mumford, P. W., Purpura, M., Jager, R., & Kerksick, C. M. (2024). Ingesting dileucine, but not leucine, increases lower body strength and performance following resistance training: A double-blind, randomized, placebo-controlled trial. PLOS ONE, 19(12), Article e0312997. https://doi.org/10.1371/journal.pone.0312997
- Aguilera, J. A., Tinline-Goodfellow, C. T., Lees, M. J., Kortebi, I., West, D. W. D., Abou Sawan, S., Sharma, M., Bashir, R., Barnes, T. M., Ulanov, A. V., Burd, N. A., & Moore, D. R. (2025). Essential amino acids supplemented with dileucine support whole-body anabolism after resistance exercise and serum-stimulated cell-based anabolism. Journal of the International Society of Sports Nutrition, 22(1), Article 2590090. https://doi.org/10.1080/15502783.2025.2590090
- Zupančič, Ž., Provenzano, G. M., Chen, C., Irwin, G. L., Ulanov, A. V., & Burd, N. A. (2026). Whole-food protein sources differentially modulate postprandial plasma dileucine profiles in the post-exercise state. Molecular Nutrition & Food Research, 70(19), Article e70628. https://doi.org/10.1002/mnfr.70628